Ghumman Ghulam Mujtaba, Fatima Huda, Singh Gunbir, Khalid Taha, Ayoubi Mohamed
Internal Medicine, St. Vincent Mercy Medical Center, Toledo, USA.
Internal Medicine, MedStar Union Memorial Hospital, Baltimore, USA.
Cureus. 2023 Jan 10;15(1):e33615. doi: 10.7759/cureus.33615. eCollection 2023 Jan.
Eltrombopag is a second-line therapy for refractory thrombocytopenia from immune thrombocytopenic purpura (ITP). The medication is generally well tolerated but can lead to adverse thromboembolic complications in rare instances. We present a case of lower extremity deep vein thrombosis with bilateral pulmonary embolism in an ITP patient receiving eltrombopag. The patient underwent catheter-directed thrombolysis for pulmonary embolism. Eltrombopag was stopped on discharge, considering the potential cause of venous thrombosis.
艾曲泊帕是治疗免疫性血小板减少性紫癜（ITP）所致难治性血小板减少症的二线疗法。该药物一般耐受性良好，但在罕见情况下可导致不良血栓栓塞并发症。我们报告一例接受艾曲泊帕治疗的ITP患者发生下肢深静脉血栓形成并伴有双侧肺栓塞的病例。该患者接受了针对肺栓塞的导管定向溶栓治疗。考虑到静脉血栓形成的潜在原因，患者出院时停用了艾曲泊帕。
